TrialF1000Research2018

Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer's disease progression.

Ilijana Begcevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.